🔗 Visit the ClinicalTrials.gov page for NCT01337518
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Androgen receptor antagonists in castration-resistant prostate cancer. | Cancer J | 2013 | 1.19 |
| 2 | The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance. | Haematologica | 2013 | 0.90 |
| 3 | Targeting the androgen receptor in the management of castration-resistant prostate cancer: rationale, progress, and future directions. | Curr Oncol | 2012 | 0.89 |
| 4 | Recent progress in pharmaceutical therapies for castration-resistant prostate cancer. | Int J Mol Sci | 2013 | 0.88 |
| 5 | Emerging molecularly targeted therapies in castration refractory prostate cancer. | Prostate Cancer | 2013 | 0.83 |
| 6 | Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer. | Int J Biol Sci | 2016 | 0.81 |
| 7 | Translational and clinical implications of the genetic landscape of prostate cancer. | Nat Rev Clin Oncol | 2016 | 0.76 |